MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Clinical trials for MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P) trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cell injection trial offers hope for rare Parkinson's-like disease
Disease control Recruiting nowThis early-stage trial tests a single injection of special brain cells (dopaminergic progenitor cells) into a specific area of the brain for people with Multiple System Atrophy (MSA), a rare and severe neurological disorder. The main goal is to check if the procedure is safe and …
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Phase: PHASE1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:32 UTC
-
New drug aleeto tested for rare brain disease – early safety check
Symptom relief Recruiting nowThis early-phase study tests whether a new drug, Aleeto, is safe and tolerable for people with Multiple System Atrophy (MSA), a rare and serious brain disorder. About 20 participants will receive the drug and be monitored for side effects and any signs of symptom improvement. The…
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Phase: EARLY_PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated May 26, 2026 09:37 UTC
-
Spinal zap trial aims to stop Parkinson's dizzy spells
Symptom relief Recruiting nowThis very early study tests whether a spinal cord stimulation device (ARC-IM Therapy) can safely help manage sudden drops in blood pressure (orthostatic hypotension) in people with Parkinson's disease or related conditions. Only 5 participants will be enrolled to check safety and…
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Phase: NA • Sponsor: Ecole Polytechnique Fédérale de Lausanne • Aim: Symptom relief
Last updated May 26, 2026 09:32 UTC
-
DNA hunt for brain disease clues
Knowledge-focused Recruiting nowThis study collects blood samples from up to 1,000 adults with PSP, CBS, or MSA and their family members to search for genes linked to these rare brain disorders. Researchers will sequence participants' DNA to find known and new genetic variants. The goal is to better understand …
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 09:27 UTC